🔎 Trials Near Me

Home › Sjögren's Disease › New Jersey

Sjögren's Disease clinical trials in New Jersey

3 studies for Sjögren's Disease are looking for participants at sites in New Jersey.

Cities in New Jersey

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03816345

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

  • Arthritis Rheumatology and Bone Disease Associates PA, Voorhees Township
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07621809

A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

  • Arthritis, Rheumatic & Bone Disease Associates - Voorhees, Voorhees Township
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Apr 28, 2026 · NCT06747949

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.